The aim of the study was to compare the safety and efficacy of sacubitril-valsartan and enalapril therapy for patients with acute decompensated heart failure.
Tsukuba trillville tsardom combination is safe and effective in acute decompensating heart failure oh cute decompensated heart failure is a condition in which signs and symptoms of heart failure suddenly worsened tsukuba trill plus they’ll certain combination has shown promising results in the treatment of symptomatic heart failure with reduced ejection fraction the
Objective of the study was to compare the efficacy and safety of tsukuba trail plus valsartan with enalopril in patients with acute decompensated heart failure following hem dynamic stabilization patience above 18 years of age with acute decompensated heart failure along with the signs and symptoms of fluid overload and with left ventricular ejection fraction less
Than or equal to 40 percent or n-terminal probe b-type natriuretic peptide concentration more than or equal to 1600 picogram per milliliter or b-type natriuretic peptide concentration more than or equal to 400 picogram per milliliter were included in the study patients who have taken tsukuba trail + valsartan within past 30 days or had acute or chronic respiratory
Disorder were excluded from the study the patients with estimated glomerular filtration rate less than 30 milliliter per minute per 1.73 meter square all patients who had history of stroke or any major cardiovascular surgery in past one month were also excluded from the study the multicenter randomized double-blind study included 881 patients that were divided
Into groups enalapril group included 441 patients and tsukuba trial plus valsartan group included 440 patients the time averaged proportional change in the concentration of n-terminal pro b-type natriuretic peptide was measured at the baseline and through hole fourth and eighth weeks the ratio of the geometric mean of the value obtained at fourth and eight weeks
Was significantly low for tsukuba trill plus valsartan group the result of the study concluded that tsukuba trill + valsartan is safe and effective in treating patients with acute decompensated heart failure following hemodynamic stabilization
Transcribed from video
Sacubitril-valsartan combination is safe and effective in acute decompensating heart failure By infocusrx today
